We surveyed social media users from vulnerable groups and found 73% got their vital news from social platforms. How can we protect these people from vaccine misinformation?
It’s quite likely this virus will never be eliminated from the world. But even so, getting vaccinated enormously reduces your risk of severe outcomes like hospitalisation and death.
The CDC first paused, then unpaused, the administration of the Johnson & Johnson COVID-19 vaccine due to concerns about blood clots. But what are those clots, and how do they form?
Licensing agreements between pharmaceutical companies and the Medicines Patent Pool, in cooperation with the WHO, could accelerate access to doses for the poorest countries.
Jamaal Abdul-Alim, The Conversation and Alvin Buyinza, The Conversation
As more people get vaccinated and different facets of society slowly reopen, challenges remain in the nation’s quest to get back to normal. Here are five articles that help illuminate the path.
COVAX, the global vaccine distribution initiative, is well behind its goal of delivering 2 billion doses this year due to under-investment, vaccine nationalism and export restrictions.
This year is a whole new ball game for pandemic politics. For a prime minister not accustomed to pressure, Scott Morrison is proving far less equipped.
African governments, firms and donor agencies should align their efforts to support the local manufacture of vaccines and other health equipment in African countries.
Kenya grapples with two major challenges in the vaccination rollout: access to sufficient doses in light of the global shortage; and vaccine hesitancy.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand